← SynDRA
JDTIC
SynDRA canonical compound SYN0000464 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | OPRK1 |
| Mechanism of action | Opioid receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Opioid receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KCNH2
- OPRD1
- OPRM1
- HDAC6
- MRGPRX2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2D6
- KSYK
- MAPK10
- MAPK8
- MAPK9
- NSD2
- SYK
Cross-references
Synonyms
- Rti-jdtic
- CHEMBL415247
- (3r)-7-Hydroxy-N-{(2s)-1-[(3r,4r)-4-(3-Hydroxyphenyl)-3,4-Dimethylpiperidin-1-Yl]-3-Methylbutan-2-Yl}-1,2,3,4-Tetrahydroisoquinoline-3-Carboxamide
- (3R)-7-Hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
- (3R)-7-HYDROXY-N-((1S)-1-{[(3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL]METHYL}-2-METHYLPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXAMIDE
- JDC
- 3C6FZ6UXC8
- compound 10 [PMID: 11495579]
- compound 10 (PMID: 11495579)
- RefChem:150455
- DTXCID90384129
- CS-0537
- UNII-3C6FZ6UXC8
- GTPL7362
- orb3029210
- SCHEMBL3894627
- SCHEMBL29484941
- SCHEMBL30007617
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N
- EX-A3812
- BDBM50130563
- AKOS027263824
- NCGC00378654-01
- HY-10486
- T11721
- BRD-K95837862-300-01-7
- atrans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl) piperidine
- Jdtic hydrochloride
- GLXC-04046
- (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide hydrochloride
- JDTic 2HCl
- UNII-VR27M77CW3
- T11721L
- F84481
- JDTic dihydrochloride?
- DA-54521
- AKOS030526902
Look up JDTIC in the interactive SynDRA portal →